Description

Dinar (ethylmethylhydroxypyridine succinate) Solution for Injections 50 mg/ml. 5 ml. Ampoules №10

Ingredients:

Each 5 ml ampoule contains 50 mg of ethylmethylhydroxypyridine succinate.

Dosage:

The recommended dosage is determined by a healthcare professional based on the individual’s condition. It is usually administered via intramuscular or intravenous injection.

Indications:

Dinar solution is indicated for the treatment of cerebrovascular disorders, cognitive impairments, and neurological conditions. It helps improve cerebral blood flow and oxygen supply to the brain.

Contraindications:

Do not use Dinar solution if you are allergic to ethylmethylhydroxypyridine succinate or any other ingredients in the product. It is not recommended for use in pregnant women or individuals with severe renal impairment.

Directions:

Administer the solution as directed by a healthcare provider. Do not exceed the recommended dosage. It is important to follow aseptic techniques during administration to prevent infections.

Scientific Evidence:

Dinar solution’s efficacy in improving cognitive function and neurological outcomes has been supported by clinical studies. Research has shown that ethylmethylhydroxypyridine succinate acts as a neuroprotective agent, enhancing neuronal survival and function.

Additional Information:

Pharmacological Effects: Dinar solution exerts its effects by increasing cerebral blood flow, reducing oxidative stress, and enhancing neurotransmitter function in the brain. These actions contribute to its neuroprotective and cognitive-enhancing properties.

Clinical Trials: Several clinical trials have demonstrated the benefits of Dinar solution in improving symptoms of cerebrovascular disorders and cognitive dysfunction. Patients treated with ethylmethylhydroxypyridine succinate showed significant improvements in cognitive function and quality of life.